These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33389290)

  • 1. ASO Author Reflections: Is Neoadjuvant Chemotherapy Associated with Acceptable Short-Term Outcomes for Pancreatic Cancer?
    Kamarajah SK; Dahdaleh F
    Ann Surg Oncol; 2021 Apr; 28(4):1906-1907. PubMed ID: 33389290
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Neoadjuvant Chemotherapy Switch: Optimizing Neoadjuvant Treatment Sequencing in Pancreas Cancer.
    Alva-Ruiz R; Truty MJ
    Ann Surg Oncol; 2022 Mar; 29(3):1592-1593. PubMed ID: 34705142
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.
    Adam MA; Paniccia A
    Ann Surg Oncol; 2021 Jul; 28(7):3808-3809. PubMed ID: 33475885
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Novel Evidence on Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer with Arterial Involvement.
    Ikenaga N; Miyasaka Y; Ohtsuka T; Nakamura M
    Ann Surg Oncol; 2023 Jan; 30(1):203-204. PubMed ID: 36131116
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer-Standard of Care or Still Worth Debating?
    Chawla A; Wang J
    Ann Surg Oncol; 2020 Apr; 27(4):1201-1202. PubMed ID: 31848817
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Postoperative Chemotherapy After Neoadjuvant Therapy and Pancreatectomy for Pancreatic Cancer: Balancing Patient Physiology and Disease Biology.
    Kamarajah SK; Dahdaleh F
    Ann Surg Oncol; 2021 Oct; 28(11):6803-6804. PubMed ID: 33774772
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Neoadjuvant Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma-Predictors of Disease Progression and Performance Status Decline.
    Paniccia A; Zureikat A
    Ann Surg Oncol; 2020 Aug; 27(8):2972-2973. PubMed ID: 32124127
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis.
    Liu H; Zureikat A
    Ann Surg Oncol; 2020 Oct; 27(10):3961-3962. PubMed ID: 32372314
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma.
    Murthy P; Boone BA
    Ann Surg Oncol; 2020 Mar; 27(3):907-908. PubMed ID: 31823171
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial.
    Stoop TF; Seelen LWF; van 't Land FR; van Eijck CHJ; van Santvoort HC; Besselink MG;
    Ann Surg Oncol; 2024 Apr; 31(4):2658-2659. PubMed ID: 38093164
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Multimodality Therapy for Patients with Pancreatic Cancer: Neoadjuvant Therapy for All?
    da Costa WL; Massarweh NN
    Ann Surg Oncol; 2021 Jun; 28(6):3196-3197. PubMed ID: 33221979
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer.
    Andrianello S; Marchegiani G; Salvia R
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):810-811. PubMed ID: 30374921
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer.
    Chopra A; Beane JD
    Ann Surg Oncol; 2021 Nov; 28(12):7770-7771. PubMed ID: 34028634
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.
    Tomioka A; Uchiyama K
    Ann Surg Oncol; 2021 Jul; 28(7):3798-3799. PubMed ID: 33236253
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma.
    O'Shea AE; Carpenter EL; Nelson DW; Vreeland TJ
    Ann Surg Oncol; 2022 Sep; 29(9):6029-6030. PubMed ID: 35583695
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated with Liver Recurrence.
    Kubo H; Ohgi K; Sugiura T; Ashida R; Yamada M; Otsuka S; Yamazaki K; Todaka A; Sasaki K; Uesaka K
    Ann Surg Oncol; 2022 Aug; 29(8):5003-5004. PubMed ID: 35381935
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Dissecting the Risk and Impact of Venous Thromboembolism During Neoadjuvant Treatment and the Subsequent Perioperative Period for Patients With Pancreatic Adenocarcinoma.
    Boone BA
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):590-591. PubMed ID: 31016487
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Neoadjuvant Therapy for Ampullary and Duodenal Adenocarcinoma-What Do We Know?
    Zhang C; Reames BN
    Ann Surg Oncol; 2024 Feb; 31(2):808-809. PubMed ID: 37993747
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: A Novel Combination Index of Sialyl-Lewis Antigen-Related Tumor Markers Enhances Predictive Significance in Patients with a Modest Radiological Response to Neoadjuvant Treatment for Pancreatic Cancer.
    Miyahara S; Takahashi H; Akita H; Sasaki K; Mukai Y; Iwagami Y; Hasegawa S; Yamada D; Tomimaru Y; Noda T; Wada H; Kobayashi S; Doki Y; Eguchi H
    Ann Surg Oncol; 2024 May; 31(5):2971-2972. PubMed ID: 38363472
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Future Prospects of Neoadjuvant Chemotherapy for Gastric Cancer.
    Kano M; Matsubara H
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):721-722. PubMed ID: 31797227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.